knowledge -WSS

knowledge

author：focus 2025-09-30 08:53:14 - browse：29824

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： J&J expands global access to TB drug amid advocacy campaign

hotspot

WSS

Involuntary treatment for addiction doesn't work

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Why police arrested suspected Gilgo Beach killer away from his house

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Who gets to use the title 'doctor'?

hotspot

knowledge

focus

Cancer drug shortages should be causing more outrage

Congress likely to miss an opportunity to fix drug shortages issue

Supreme Court strikes down use of affirmative action

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Cancer drug shortages should be causing more outrage

Congress likely to miss an opportunity to fix drug shortages issue

Activists slam private health insurers over coverage restrictions

The new HIV moral panic

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Congress: Eradicate hepatitis C and reduce the deficit

hotspot

Europe sees delivery challenges ahead on Alzheimer's therapies

Care demand spikes challenge UnitedHealth’s provider arm

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Celiac disease study examines precisely how gluten triggers injury

Addiction experts warn against a second 'war on drugs'

explore

hotspot

Wikipedia

explore